Next, we analyzed whether an additional 68Ga-PSMA PET/CT have potential benefit on nomogram-based therapy choices of high-risk PC patients, including sparing unnecessary ePLND in PC patients with non-regional LNMs. Here, FOLH1 is linked to pachyonychia congenita.